2022
DOI: 10.21037/atm-22-1135
|View full text |Cite
|
Sign up to set email alerts
|

Screening and identification of osteoarthritis related differential genes and construction of a risk prognosis model based on bioinformatics analysis

Abstract: Background: Searching for the production mechanism of synovial lesions helps to find precise therapeutic targets and improve prognosis. The previous identification and screening of differential genes in osteoarthritis (OA) pathogenesis were well combined to further build a risk prognosis model of OA, which is beneficial to the diagnosis and treatment of patients with OA. Methods:The synovia-related chip data sets GSE82107, GSE12021, GSE55457, and GSE55235 were downloaded from the public database of Gene Expres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 36 publications
0
5
0
Order By: Relevance
“…Therefore, many efforts have been devoted to seeking reliable diagnosis biomarkers in recent years, and some novel molecules as OA diagnosis markers have been reported, such as ATF3 [ 22 ], Apolipoprotein D [ 23 ], and CXCL13 [ 24 ]. The rapid development of genomic sequencing technology and big-data analysis methods represented by machine learning generates new opportunities to disclose novel biomarkers and to develop novel diagnostic tools, and many achievements have been obtained in OA [ 25 27 ]. Nevertheless, the reports about OA diagnosis models based on machine algorithms are relatively rare at the moment.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, many efforts have been devoted to seeking reliable diagnosis biomarkers in recent years, and some novel molecules as OA diagnosis markers have been reported, such as ATF3 [ 22 ], Apolipoprotein D [ 23 ], and CXCL13 [ 24 ]. The rapid development of genomic sequencing technology and big-data analysis methods represented by machine learning generates new opportunities to disclose novel biomarkers and to develop novel diagnostic tools, and many achievements have been obtained in OA [ 25 27 ]. Nevertheless, the reports about OA diagnosis models based on machine algorithms are relatively rare at the moment.…”
Section: Discussionmentioning
confidence: 99%
“…The GSE55457 gene expression profiles were downloaded from the GEO database [https://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE55457; GPL96 platform, Affymetrix Human Genome U133A Array] (27). The GSE55457 dataset contains data from 79 samples, including 20 healthy control individuals, 33 patients with RA and 26 patients with osteoarthritis.…”
Section: Methodsmentioning
confidence: 99%
“…To identify differentially expressed genes (DEGs) in RA, the GEO was used to assess RA data. The GSE55457 gene expression profiles were downloaded from the GEO database [ ; GPL96 platform, Affymetrix Human Genome U133A Array] ( 27 ). The GSE55457 dataset contains data from 79 samples, including 20 healthy control individuals, 33 patients with RA and 26 patients with osteoarthritis.…”
Section: Methodsmentioning
confidence: 99%
“…The hub genes ( 33 ) in key positions in the PPI network were screened with a variety of algorithms through the cytoHubba plug-in of Cytoscape ( 34 ). The obtained hub genes were reintroduced into the STRING website to determine the PPI interaction ( 35 ).…”
Section: Methodsmentioning
confidence: 99%